-
NAYA Biosciences (NAYA) Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
-
NAYA Biosciences (NAYA) Files for 10M Unit Offering
-
INVO Bioscience (INVO) Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences (NAYA)

